Not Signed In -
Rofecoxib |
Vioxx; Withdrawn from the market |
Rofecoxib Systematic (IUPAC) name 4-(4-methylsulfonylphenyl)-3-phenyl-5H-furan-2-one Identifiers CAS number 162011-90-7 ATC code M01AH02 PubChem 5090 DrugBank APRD00151 Chemical data Formula C17H14O4S Mol. weight 314.357 g/mol Pharmacokinetic data Bioavailability 93% Protein binding 87% Metabolism hepatic Half life 17 hours Excretion biliary/renal Therapeutic considerations Pregnancy cat. C (Australia) Legal status withdrawn Routes oral Ro ...
Wikipedia - [full article]
Rofecoxib News Headlines
- COX-2 drugs may raise risk of repeat heart attack
Reuters - Mon, 29 Jan 2007 05:13 EST
- Study Finds That Vioxx Reduces The Risk Of Colorectal Polyps
ScienceDaily - Thu, 31 Aug 2006 03:00 EST
- Vioxx Reduces The Risk Of Colorectal Polyps, Study Finds
MedicalNewsToday - Fri, 01 Sep 2006 08:00 EST
- Regular Use Of Selective COX-2 Inhibitors Decreases Risk Of Breast Cancer
ScienceDaily - Mon, 30 Jan 2006 03:00 EST
- Chemical imbalance may explain Vioxx''s cardiac danger
MedicalNewsToday - Wed, 14 Sep 2005 11:00 EST
- Chemical Imbalance May Explain Painkiller''s Cardiac Danger
ScienceDaily - Mon, 19 Sep 2005 02:00 EST
- Aspirin Might Prevent Vioxx Cardiac Damage
ScienceDaily - Wed, 14 Sep 2005 02:00 EST
email this page
print this page
bookmark this page
feedback on this page
